New hope for lung cancer: Pre-Surgery drug trial launches
NCT ID NCT05714891
First seen Nov 20, 2025 · Last updated Jun 13, 2026 · Updated 24 times
Summary
This study tests new drug combinations given before surgery for non-small cell lung cancer. The goal is to see which treatments shrink tumors most effectively, helping doctors choose the best options for future patients. About 4 people with early-stage lung cancer that can be removed surgically are taking part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHUM-Centre Hospitalier de l'Universite de Montreal
Montreal, Quebec, H2X 3E4, Canada
-
CancerCare Manitoba
Winnipeg, Manitoba, R3E 0V9, Canada
-
Kingston Health Sciences Centre
Kingston, Ontario, K7L 2V7, Canada
-
London Health Sciences Centre Research Inc.
London, Ontario, N6A 5W9, Canada
-
Ottawa Hospital Research Institute
Ottawa, Ontario, K1H 8L6, Canada
-
The Research Institute of the McGill University
Montreal, Quebec, H4A 3J1, Canada
-
University Health Network
Toronto, Ontario, M5G 2M9, Canada
-
University Institute of Cardiology and
Québec, Quebec, G1V 4G5, Canada
Conditions
Explore the condition pages connected to this study.